OBM (A) has access to one of the world’s largest commercially available tissue banks. With this asset, OBM has developed a proprietary biomarker discovery and validation platform that allows rapid advancement of own products and revenue generation from partners. Current customers include Boehringer Ingelheim, Roche, Medarex etc.
ORIDIS BIOMED Forschungs- und Entwicklungs GmbH
Elisabethstraße 84 / 1.OG
A-8010 Graz
Reisnerstrasse 40/3
A-1030 Vienna
Tel.: +43 (1) 513 10 72
Fax: +43 (1) 513 10 72-200
office@gamma-capital.com
www.gamma-capital.com